UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 199

Sortiert nach

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Blood, 2021-03, Vol.137 (11), p.1468-1477

2021

Volltextzugriff (PDF)

Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1

Leukemia, 2015-08, Vol.29 (8), p.1702-1712

2015

Volltextzugriff (PDF)

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma

Leukemia, 2017-01, Vol.31 (1), p.83-91

2017

Volltextzugriff (PDF)

Efficacy of Lenalidomide in Myelodysplastic Syndromes

The New England journal of medicine, 2005-02, Vol.352 (6), p.549-557

2005

Volltextzugriff (PDF)

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213

Annals of oncology, 2013-06, Vol.24 (6), p.1587-1593

2013

Volltextzugriff (PDF)

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016

Hematological oncology, 2023-06, Vol.41 (S2), p.116-117

2023

Volltextzugriff (PDF)

Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)

Hematological oncology, 2023-06, Vol.41 (S2), p.582-584

2023

Volltextzugriff (PDF)

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Annals of oncology, 2010-06, Vol.21 (6), p.1196-1202

2010

Volltextzugriff (PDF)

Array-based DNA methylation profiling in follicular lymphoma

Leukemia, 2009-10, Vol.23 (10), p.1858-1866

2009

Volltextzugriff (PDF)

SOMATIC ALTERATIONS IN FOLLICULAR LYMPHOMA ASSOCIATE WITH UNIQUE TUMOR‐CELL TRANCRIPTIONAL STATES AND TUMOR‐IMMUNE MICROENVIRONMENTS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

THE TOPOLOGY OF MYC REARRANGEMENTS IN DOUBLE‐HIT LYMPHOMA IS CONSTRAINED BY THE PRECEDING IGH ‐BCL2 REARRANGEMENT – AN LLMPP PROJECT

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

REDUCED BCL2 EXPRESSION SUGGESTS ALTERNATIVE SURVIVAL MECHANISMS IN HIV(+) DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) OF GERMINAL CENTER ORIGIN

Hematological oncology, 2019-06, Vol.37 (S2), p.198-198

2019

Volltextzugriff (PDF)

P1287: DISTINGUISHING BETWEEN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA AND DIFFUSE LARGE B‐CELL LYMPHOMA USING THE LYMPH3CX GENE EXPRESSION PROFILING ASSAY

HemaSphere, 2022-06, Vol.6 (Suppl), p.1172-1173

2022

Volltextzugriff (PDF)

Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma

Blood cancer journal (New York), 2017-04, Vol.7 (4), p.e553-e553

2017

Volltextzugriff (PDF)

Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features

American journal of clinical pathology, 2000-07, Vol.114 (1), p.66-75

2000

Volltextzugriff (PDF)

Mechanisms underlying thrombocytopenia in the neonatal intensive care unit

Acta Paediatrica, 2002-09, Vol.91 (s438), p.66-73

2002

Volltextzugriff (PDF)

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

Haematologica (Roma), 2009-11, Vol.94 (11), p.1555-1562

2009

Volltextzugriff (PDF)

Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia

Leukemia, 2005-02, Vol.19 (2), p.308-310

2005

Volltextzugriff (PDF)

Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature

Leukemia, 2000-06, Vol.14 (6), p.1044-1051

2000

Volltextzugriff (PDF)

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

Haematologica (Roma), 2012-06, Vol.97 (6), p.937-942

2012

Volltextzugriff (PDF)

A bone marrow biopsy technique suitable for use in neonates

British journal of haematology, 1999-11, Vol.107 (2), p.458-460

1999

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(173)

Publikationsform

Artikel
(199)

Sprache

Englisch
(199)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Life Sciences & Biomedicine
(107)
Humans
(106)
Biological And Medical Sciences
(53)
Female
(50)
Medical Sciences
(50)
Male
(49)
Hematology
(45)
Adult
(38)
Middle Aged
(38)
Hematologic And Hematopoietic Diseases
(35)
Aged
(30)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(29)
Prognosis
(28)
Lymphoma
(26)
Oncology
(26)
Pediatrics
(25)
Pathology
(22)
Lymphoma, Large B-Cell, Diffuse - Genetics
(21)
Adolescent
(20)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(51)
American Journal Of Clinical Pathology
(15)
Pediatrics
(14)
Hematological Oncology
(11)
Haematologica
(9)
Journal Of Clinical Oncology
(7)
Leukemia
(6)
Blood Advances
(5)
Cancer Research
(5)
Nature
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma

Efficacy of Lenalidomide in Myelodysplastic Syndromes

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016

Venetoclax, ibrutinib, prednisone, obinutuzumab, and lenalidomide (ViPOR) in relapsed/refractory (R/R) and treatment‐naïve (TN) mantle cell lymphoma (MCL)

Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study

Array-based DNA methylation profiling in follicular lymphoma

SOMATIC ALTERATIONS IN FOLLICULAR LYMPHOMA ASSOCIATE WITH UNIQUE TUMOR‐CELL TRANCRIPTIONAL STATES AND TUMOR‐IMMUNE MICROENVIRONMENTS

CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT

THE MUTATIONAL LANDSCAPE OF DOUBLE/TRIPLE‐HIT HIGH‐GRADE B‐CELL LYMPHOMA WITH BCL2 REARRANGEMENT (DH/TH‐ BCL2 ) – AN LLMPP PROJECT

THE TOPOLOGY OF MYC REARRANGEMENTS IN DOUBLE‐HIT LYMPHOMA IS CONSTRAINED BY THE PRECEDING IGH ‐BCL2 REARRANGEMENT – AN LLMPP PROJECT

REDUCED BCL2 EXPRESSION SUGGESTS ALTERNATIVE SURVIVAL MECHANISMS IN HIV(+) DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) OF GERMINAL CENTER ORIGIN

P1287: DISTINGUISHING BETWEEN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA AND DIFFUSE LARGE B‐CELL LYMPHOMA USING THE LYMPH3CX GENE EXPRESSION PROFILING ASSAY

Whole-exome analysis reveals novel somatic genomic alterations associated with cell of origin in diffuse large B-cell lymphoma

Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Mechanisms underlying thrombocytopenia in the neonatal intensive care unit

SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia

Microsatellite instability is not a defining genetic feature of acute myeloid leukemogenesis in adults: results of a retrospective study of 132 patients and review of the literature

Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone

A bone marrow biopsy technique suitable for use in neonates

Suchergebnisse filtern